What he says about the team: “Every day, I am inspired by the innovative work our teams conduct as we guide sponsors on the complex journey of bringing new therapies and healthcare solutions to deserving patients.”

Ron has taken on the role of Chief Executive Officer for the merged entity of Sequoia Biotech Consulting and Syner-G Biopharma Group, leveraging 30 years of experience in the life sciences sector. With extensive global expertise in the bio/pharma industry, Ron has held various executive leadership positions in both public and private equity-backed companies, successfully serving as a Business Unit Head and Sales Executive. A common theme throughout his career is a passion for building expert teams and businesses, providing unparalleled support in the development of life-saving therapies.

Prior to joining Syner-G in 2022, Ron was the Chief Operating Officer at Cytel, responsible for driving profitable growth of their Services business. At Parexel, he was the Global Head of Consulting, leading the 1000+ employee business on a robust growth journey via a combination of organic growth, entering new markets, and acquisitions.

Prior to Cytel, Ron held various positions spanning 25 years at Parexel, where he consistently delivered high levels of growth through increased sales of existing services while developing new markets and expanding into new business areas. Under his leadership, the Consulting Services Business delivered 16% revenue CAGR at operating income levels exceeding 25%.

During his season leading Parexel Consulting, Ron successfully developed and launched Parexel’s regulatory outsourcing service, which exceeded expectations by capturing several new partnerships in the initial 18 months, representing $50M USD in new revenue. He also led the identification, due diligence, and integration of two acquisitions, allowing Parexel to further differentiate its global product development services and provide access to new client buyers to drive growth.

During Ron’s tenure in sales at Parexel, he transformed the sales organization from a traditional business development function focused on RFP-style selling into an integrated global team highly effective at consultative selling and account management. While in the Clinical Research Services Business, he oversaw Phase I through Phase IV research and led the transformation of the function from a regional-based service to a global function, enhancing operational and financial controls. These improvements delivered better profitability and customer satisfaction, and in 2019, Parexel’s Clinical Research unit was ranked #1 among global CROs for leadership in Phase II-III services by ISR.

Ron graduated from the University of Massachusetts Amherst with a Bachelor of Science in Mechanical Engineering.